Division of Haematology, United Medical Schools of Guy's, St Thomas' Campus, SE1 7EH, London, UK.
Cytotechnology. 1987 Oct;1(1):33-6. doi: 10.1007/BF00351119.
In classical t(9;22) translocation, as observed in chronic granulocytic leukemia (CGL), a hybrid DNA unit is produced, including a rearranged PHL gene, previously known as bcr (breakpoint cluster region) plus the translocated c-abl gene from chromosome 9: a hybrid bcr-abl protein, p210 is formed, with increased tyrosine kinase activity. Such DNA rearrangement, with a p210 protein synthesis, is also found in cases of Philadelphia-positive acute lymphoblastic leukemia (ALL), but in apparently similar cases the bcr gene is not rearranged, and a novel p190 abl-related protein can be found; c-abl rearrangement has also been observed.It is thus established that correlations between cytogenetic and molecular events can be found in CGL and ALL, as in other haemopoietic malignancies: translocation and possible rearrangement of the c-abl oncogene seem of particular importance in this case.
在慢性粒细胞白血病(CGL)中观察到的经典 t(9;22) 易位中,会产生一个杂交 DNA 单元,包括先前称为 bcr(断裂簇区域)的重排 PHL 基因加上来自染色体 9 的易位 c-abl 基因:形成具有增加的酪氨酸激酶活性的杂交 bcr-abl 蛋白 p210。这种 DNA 重排以及 p210 蛋白的合成也存在于费城阳性急性淋巴细胞白血病(ALL)中,但在明显类似的情况下,bcr 基因没有重排,可以发现一种新的 p190 abl 相关蛋白;还观察到 c-abl 重排。因此,在 CGL 和 ALL 中,就像在其他造血恶性肿瘤中一样,可以发现细胞遗传学和分子事件之间的相关性:c-abl 癌基因的易位和可能的重排在这种情况下似乎特别重要。